Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report

INTRODUCTION: Paraganglioma (PGL) is a rare neuroendocrine tumor. Currently, the malignancy is defined as the presence of metastatic spread at presentation or during follow-up. Several gene mutations are listed in the pathogenesis of PGL, among which succinate dehydrogenase (SDHX), particularly the...

Descripción completa

Detalles Bibliográficos
Autores principales: Stigliano, Antonio, Lardo, Pina, Cerquetti, Lidia, Aschelter, Anna Maria, Matarazzo, Iolanda, Capriotti, Gabriela, Schiavi, Francesca, Marchetti, Paolo, Nardone, Maria Rosaria, Petrangeli, Elisa, Toscano, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078645/
https://www.ncbi.nlm.nih.gov/pubmed/30045248
http://dx.doi.org/10.1097/MD.0000000000010904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078645/
https://www.ncbi.nlm.nih.gov/pubmed/30045248
http://dx.doi.org/10.1097/MD.0000000000010904

Ejemplares similares